Literature DB >> 9257314

Endothelial cell expression of intercellular adhesion molecule 1 in experimental posthemorrhagic vasospasm.

A K Sills1, R E Clatterbuck, R C Thompson, P L Cohen, R J Tamargo.   

Abstract

OBJECTIVE: The exposure of large intracranial arteries to blood after an aneurysmal subarachnoid hemorrhage leads to a cascade of morphological and physiological changes in the vessels, a condition generally described as vasospasm. This response to the periadventitial deposition of blood is mediated in part by the endothelial layer of the vessel. This study was undertaken to examine the role of endothelial cell expression of intercellular adhesion molecule 1 (ICAM-1) in the initiation and regulation of this response.
METHODS: The femoral artery model of vasospasm was used in rats (65 animals, 130 arteries). In each rat, one artery was exposed to blood and the contralateral vessel was exposed to saline, so that each animal served as its own control. Animals were perfused and killed at sequential time points, from 1 hour to 20 days after blood exposure. The vessels were examined immunohistochemically and histologically for the presence of ICAM-1 and morphological features of vasospasm, respectively.
RESULTS: Endothelial cell ICAM-1 immunoreactivity was extensively increased in only the blood-exposed vessels, beginning 3 hours after clot placement and persisting for 24 hours. ICAM-1 immunoreactivity returned to baseline by 48 hours after blood exposure. The influx of inflammatory cells correlated directly with the time and location of increased ICAM-1 expression. Peak arterial remodeling was observed on the blood-exposed side 8 to 12 days after clot placement, as quantified by measurements of increased wall thickness, decreased lumen size, and increased collagen content.
CONCLUSION: Endothelial cell ICAM-1 expression seems to be an early and specific signal used by a vessel in response to the deposition of blood periadventitially. This molecule may be a marker for vessels likely to undergo subsequent morphological remodeling and vasospasm.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9257314     DOI: 10.1097/00006123-199708000-00025

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  12 in total

1.  Early circulating levels of endothelial cell activation markers in aneurysmal subarachnoid haemorrhage: associations with cerebral ischaemic events and outcome.

Authors:  C J M Frijns; R Fijnheer; A Algra; J A van Mourik; J van Gijn; G J E Rinkel
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-01       Impact factor: 10.154

2.  Serum concentration of adhesion molecules in patients with delayed ischaemic neurological deficit after aneurysmal subarachnoid haemorrhage: the immunoglobulin and selectin superfamilies.

Authors:  J J Nissen; D Mantle; B Gregson; A D Mendelow
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-09       Impact factor: 10.154

3.  A novel inhibitor of inflammatory cytokine production (CNI-1493) reduces rodent post-hemorrhagic vasospasm.

Authors:  George Bowman; Robert H Bonneau; Vernon M Chinchilli; Kevin J Tracey; Kevin M Cockroft
Journal:  Neurocrit Care       Date:  2006       Impact factor: 3.210

4.  Timing of ICAM-I Expression in a Canine Model of Post-Haemorrhagic Cerebral Vasospasm.

Authors:  T Abruzzo; G G Shengelaia; H J Cloft; G Thaxton; P Dudley; F Tong; J E Dion
Journal:  Interv Neuroradiol       Date:  2001-05-15       Impact factor: 1.610

Review 5.  The blood-brain barrier and the neurovascular unit in subarachnoid hemorrhage: molecular events and potential treatments.

Authors:  Peter Solár; Alemeh Zamani; Klaudia Lakatosová; Marek Joukal
Journal:  Fluids Barriers CNS       Date:  2022-04-11

6.  Effectiveness of papaverine cisternal irrigation for cerebral vasospasm after aneurysmal subarachnoid hemorrhage and measurement of biomarkers.

Authors:  Jae Hoon Kim; Hyeong-Joong Yi; Yong Ko; Young-Soo Kim; Dong-Won Kim; Jae-Min Kim
Journal:  Neurol Sci       Date:  2013-12-03       Impact factor: 3.307

Review 7.  Adhesion molecules in CNS disorders: biomarker and therapeutic targets.

Authors:  Qingyi Ma; Sheng Chen; Damon Klebe; John H Zhang; Jiping Tang
Journal:  CNS Neurol Disord Drug Targets       Date:  2013-05-01       Impact factor: 4.388

8.  A glutamate receptor antagonist, S-4-carboxyphenylglycine (S-4-CPG), inhibits vasospasm after subarachnoid hemorrhage in haptoglobin 2-2 mice [corrected].

Authors:  Tomas Garzon-Muvdi; Gustavo Pradilla; Jacob J Ruzevick; Matthew Bender; Lindsay Edwards; Rachel Grossman; Ming Zhao; Michelle A Rudek; Gregory Riggins; Andrew Levy; Rafael J Tamargo
Journal:  Neurosurgery       Date:  2013-10       Impact factor: 4.654

9.  Influence of Fever and hospital-acquired infection on the incidence of delayed neurological deficit and poor outcome after aneurysmal subarachnoid hemorrhage.

Authors:  G Logan Douds; Bi Tadzong; Akash D Agarwal; Satish Krishnamurthy; Erik B Lehman; Kevin M Cockroft
Journal:  Neurol Res Int       Date:  2012-10-02

Review 10.  Therapeutic implications of estrogen for cerebral vasospasm and delayed cerebral ischemia induced by aneurysmal subarachnoid hemorrhage.

Authors:  Dale Ding; Robert M Starke; Aaron S Dumont; Gary K Owens; David M Hasan; Nohra Chalouhi; Ricky Medel; Chih-Lung Lin
Journal:  Biomed Res Int       Date:  2014-03-02       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.